This webinar will cover specifications for Dissolution Performance Verification Standard – Prednisone Reference Standards (DPVS-Prednisone RS) that were developed and the benefits of the new standard, such as less sensitive to media degassing, low tablet-to-tablet variability, and delivering more consistent results for App 1 and App 2. The DPVS – Prednisone Reference Standard became official May 1, 2023, as indicated in the USP General Chapter <711>. The new formulation helps address the challenges faced by industry and ensures the users confidence in the overall dissolution system suitability.

Subject area:
Drug Products & APIs

Objectives (If applicable):
N/A

Target Audience (If applicable):
Dissolution Instrument manufacturers, QA/QC, R&D, CROs, pharma manufacturers, and dissolution service providers.